Further, we observed using colon cancer stem cells marker CD133 [32] and CD44v6, a marker of constitutive and reprogrammed CSCs driving colon cancer metastasis [36] that the xenograft-derived cells have a lower stem cell content and activity. Here, PROM1 is linked to malignant colon neoplasm.